Company Dr. Lal PathLabs Limited Bombay S.E.

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Dr. Lal PathLabs Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

Market Closed - Bombay S.E. Other stock markets 11:00:49 29/04/2024 BST			5-day change	1st Jan Change
2,349 ^INR	-1.60%		+3.63%	-8.76%

04-26	Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024	CI
03-18	Dr Lal Pathlabs Names CEO	MT

Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.

Number of employees: 4,048

INR in Million	2022	Weight	2023	Weight	Delta
Laboratories for Carrying Out Pathological Investigations 100.0 %	20,873	100.0 %	20,166	100.0 %	-3.38%
Other 0.0 %	1	0.0 %	2	0.0 %	+85.27%

INR in Million	2022	Weight	2023	Weight	Delta
India 98.9 %	20,734	99.3 %	19,949	98.9 %	-3.79%
International 1.1 %	140	0.7 %	220	1.1 %	+57.66%

Managers	Title	Age	Since
Bharath Uppiliappan CEO	Chief Executive Officer	-	30/09/16
Ved Prakash Goel DFI	Director of Finance/CFO	-	31/12/05
Arvind Lal CHM	Chairman	74	13/02/95
Munender Soperna CTO	Chief Tech/Sci/R&D Officer	-	31/08/07
Vinay Gujral CMP	Compliance Officer	-	30/11/19
Vandana Lal CTO	Chief Tech/Sci/R&D Officer	66	13/02/95
Manoj Garg HRO	Human Resources Officer	-	-
Om Prakash Manchanda PRN	Corporate Officer/Principal	58	31/01/05

Members of the board	Title	Age	Since
Gurinder Singh Kalra BRD	Director/Board Member	58	26/07/23
Arun Kumar Sardari Duggal BRD	Director/Board Member	77	20/08/15
Arvind Lal CHM	Chairman	74	13/02/95
Vandana Lal CTO	Chief Tech/Sci/R&D Officer	66	13/02/95
Om Prakash Manchanda PRN	Corporate Officer/Principal	58	31/01/05
Rajit Mehta BRD	Director/Board Member	-	26/07/23
Rahul Sharma BRD	Director/Board Member	63	21/07/05
Archana Lal Erdmann BRD	Director/Board Member	43	16/05/19
Somya Satsangi BRD	Director/Board Member	54	07/02/19
Rohit Bhasin BRD	Director/Board Member	64	07/11/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	83,557,330	36,164,902 ( 43.28 %)	344,253 ( 0.4120 %)	43.28 %

Name	Equities	%	Valuation
Arvind Lal 31.64 %	26,415,443	31.64 %	717 M ₹
Vandana Lal 19.27 %	16,082,327	19.27 %	436 M ₹
UTI Asset Management Co. Ltd. (Investment Management) 6.054 %	5,053,676	6.054 %	137 M ₹
Archana Lal Erdmann 2.029 %	1,693,751	2.029 %	46 M ₹
Anjaneya Lal 2.024 %	1,689,614	2.024 %	46 M ₹
Life Insurance Corporation of India (Investment Portfolio) 1.475 %	1,231,246	1.475 %	33 M ₹
Om Prakash Manchanda 1.277 %	1,066,169	1.277 %	29 M ₹
First Sentier Investors (Hong Kong) Ltd. 1.141 %	952,626	1.141 %	26 M ₹
Al Mehwar Commercial Investments LLC 1.057 %	882,188	1.057 %	24 M ₹
SBI Funds Management Ltd. 0.8828 %	736,918	0.8828 %	20 M ₹

Dr. Lal PathLabs Ltd.

12th Floor, Tower B, SAS Tower Medicity, Sector-38

122001, Gurgaon

+91 12 4301 6500

http://www.lalpathlabs.com

address Dr. Lal PathLabs Limited(LALPATHLAB)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,388 INR

Average target price

2,455 INR

Spread / Average Target

+2.78%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-16.58%	8.25B
RADNET, INC.	+39.20%	3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.11%	2.46B
SYNLAB AG	-7.36%	2.46B
FLEURY S.A.	-19.01%	1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.66%	1.21B
METROPOLIS HEALTHCARE LIMITED	+7.56%	1.11B
ADICON HOLDINGS LIMITED	-15.03%	1.03B
OPKO HEALTH, INC.	-16.56%	878M

Medical & Diagnostic Laboratories